Key Highlights

● Odysight.ai shares have risen to about $3.68, up 8.24%, on thin turnover of only about 25,300 shares, with relative Volume below the stock's own recent average.

● The company builds miniaturized video-in-the-loop visual sensors and AI software for condition-based monitoring and predictive maintenance across aerospace and defense applications.

● Revenue for the first half of 2026 was roughly $0.5 million, down sharply from about $2.4 million in the first half of 2025, even as the company disclosed its first purchase order from Boeing.

● The company recently launched a confidentially marketed public offering, a Capital raise that lets a company gauge institutional Demand privately before pricing but that still results in new shares and dilution.

Odysight.ai Inc. (NASDAQ:ODYS) has risen to about $3.68, up 8.24%, lifting the AI-visual-sensing developer's Market Value to roughly $61.9 million. The advance stands out less for its size than for its context: it came on thin turnover of only about 25,300 shares, with relative volume of just 0.68, below the stock's own recent average. For a micro-cap, that combination is a reminder that an eye-catching percentage move can reflect a low share price and a small, Illiquid float as much as any change in the underlying business.

The most accurate reading is that the stock drifted higher as investors continued to digest a busy stretch, one that delivered first-half results, a widening order Backlog anchored by a first-ever Boeing purchase order, and, less comfortably for existing holders, the launch of a dilutive stock sale.

What happened

Odysight.ai, an Israel-based, U.S.-listed company formerly known as Medigus, builds miniaturized 'video-in-the-loop' visual sensors and AI software for condition-based monitoring and predictive maintenance, technology originally rooted in medical micro-cameras and now aimed squarely at aerospace, defense and industrial machinery. Its pitch is that tiny, ruggedized cameras paired with machine-learning analytics can watch critical components, such as engines, gearboxes and cables, and flag wear before failures occur.

No single confirmed catalyst is attached to the 25 August gain. Instead, the move followed two mid-month events. On 13 August the company reported first-half 2026 financial results and detailed a string of new aerospace and defense orders, including its maiden Boeing engagement. Then, on 19 August, it announced the launch of a confidentially marketed public offering (CMPO) of common stock, a capital raise that typically weighs on a small-cap share price rather than lifting it. Against that backdrop, the 8% pop on light volume looks like post-news drift and thin-market noise rather than a discrete new development.

Inside the first-half numbers

The headline financials underline how early-stage the story remains. Revenue for the first half of 2026 was roughly $0.5 million, down sharply from about $2.4 million in the first half of 2025, as the Business shifts from legacy activity toward its inspection-and-monitoring platform. The net loss widened to about $9.5 million from $8.3 million a year earlier, and the operating loss was around $9.9 million. The company ended the period with roughly $17.6 million in cash and no debt.

The more encouraging metric is backlog, which management put at about $16.45 million as of the results, up from $14.1 million at 30 June. Backlog is not revenue, however; it represents orders that must still be delivered, recognized and, ultimately, paid for. With a half-year operating burn near $10 million against $17.6 million of cash before the new raise, the gap between promise and current sales is exactly why the company is tapping the Equity market.

The aerospace and defense pipeline

The strategic narrative rests on a growing roster of Blue-Chip and government relationships. In August the company disclosed its first purchase order from Boeing, intended to demonstrate its AI-powered predictive-maintenance solution at two Boeing sites, an early but symbolically significant entry into direct original-equipment-manufacturer work. It also cited an order from Honeywell Aerospace for a proof-of-concept on auxiliary power unit air-intake systems, with potential to expand, and a deployment tied to Elbit Systems and the Israeli Ministry of Defense.

Earlier in 2026, Odysight.ai completed its first U.S. test flights of its visual-sensing system on a UH-60 Black Hawk helicopter and signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Navy targeting carrier arresting cables. Individually, these are modest, evaluation-stage engagements; collectively, they support the company's argument that its technology is being taken seriously by demanding aerospace and defense customers. The open question is how quickly demonstrations convert into recurring, higher-volume revenue.

Capital needs and dilution

The recently launched confidentially marketed offering is the key overhang for shareholders. A confidentially marketed public offering lets a company gauge institutional demand privately before pricing, but the end result is the same: new shares, and dilution for existing holders. With sizable operating losses and a cash balance that would fund only a limited runway at the current burn rate, additional financing was arguably a matter of when, not if. Investors weighing the stock should treat further dilution, whether through this offering or future raises, as a realistic part of the thesis rather than a tail risk.

What could go wrong

The risks are considerable and specific. Revenue has fallen, not grown, year over year, so the Investment case leans heavily on a backlog that has yet to be delivered. Many of the marquee relationships are proofs-of-concept and evaluations that may never scale into large production orders. The company is deeply loss-making and reliant on capital markets, meaning dilution and financing risk are ever-present. The stock's thin float and low Liquidity cut both ways, amplifying gains but also declines, and making the shares vulnerable to sharp reversals. Finally, aerospace and defense sales cycles are long and procurement-heavy, so even genuine technical success can take years to show up in the income statement.

What to watch next

Several measurable milestones will tell investors whether the momentum is substance or sentiment. First, the terms and completion of the confidentially marketed offering, including size, price and resulting share count, will define the near-term dilution. Second, watch for conversion of the $16.45 million backlog into recognized revenue in coming quarters, the single clearest test of the model. Third, any follow-on orders or expanded scope from Boeing, Honeywell, Elbit or U.S. defense partners would validate the demonstration-to-production path. Finally, the next Quarterly Report will show whether cash burn is stabilizing and how far the post-raise Balance Sheet stretches.

Why the CMPO Terms Will Matter More Than the Backlog

Odysight.ai's move is best understood as light-volume drift in the wake of an eventful month, not a response to a fresh catalyst, and the working idea of a clean aerospace-and-AI breakout deserves a more grounded framing. The genuine positives, a maiden Boeing order, a growing backlog and credible defense engagements, sit alongside a stark reality: revenue is small and shrinking, losses are heavy, and the company has just moved to raise more equity. For investors, the appeal is leveraged exposure to a differentiated inspection technology at an early inflection; the danger is that backlog and demonstrations do not translate into durable revenue before dilution erodes the upside. Whether interest proves sustainable hinges on execution, not headlines, and the coming quarters of order conversion will be decisive.